Guidance and Visibility Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility

AAPL 273.85

+0.5%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ACAN who wrote (203177)	3/16/2010 11:05:18 AM
From: ACAN	Read Replies (1) of 208838

GNBT 9:32AM Generex Biotech announced presentation of Generex Oral-lyn (GNBT) 0.63 -0.01 : Co announced that a presentation was made in respect of Generex Oral-lyn, the Company's proprietary buccal insulin spray product. The offered conclusions that Generex Oral-lyn is as effective as regular insulin therapy in patients with Type 1 diabetes taking twice daily NPH basal insulin and it is well tolerated and safe. "We are pleased with the continuing positive reception that Generex Oral-lyn is receiving in the international scientific community... We believe that our product resembles the body's natural insulin response effectively and has the flexibility that allows patients to fine-tune their insulin treatment regimens for optimum therapeutic results."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next